Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Widefield ultra-high-density optical breast tomography system supplementing x-ray mammography.

Scientific reports·2025
Same author

Axillary Ultrasound Evaluation in Breast Cancer Patients: A Multidisciplinary Viewpoint and Middle Ground.

Journal of breast imaging·2024
Same author

Imaging Evaluation of the Axilla-A National Survey of Clinical Practice Among Radiologists.

Journal of breast imaging·2024
Same author

Music during image-guided breast biopsy reduces patient anxiety levels.

Clinical imaging·2020
Same author

Patient-Reported Breast Density Awareness and Knowledge after Breast Density Legislation Passage.

Academic radiology·2018
Same author

Intraoperative micro-computed tomography (micro-CT): a novel method for determination of primary tumour dimensions in breast cancer specimens.

The British journal of radiology·2015

Related Experiment Video

Updated: Jun 27, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Percutaneous renal tumor ablation.

Mansi Saksena1, D Gervais

  • 1Department of Radiology, Massachussetts General Hospital, Boston, 02135, USA. msaksena@partners.org

Abdominal Imaging
|December 18, 2008
PubMed
Summary
This summary is machine-generated.

Cross-sectional imaging advances have increased early renal cancer detection. Percutaneous ablation offers a new treatment option for renal cancer, with this article detailing its clinical uses, methods, and outcomes.

More Related Videos

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Related Experiment Videos

Last Updated: Jun 27, 2026

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Area of Science:

  • Urology
  • Oncology
  • Radiology

Background:

  • Increased utilization of cross-sectional imaging leads to higher detection rates of early-stage renal cancer.
  • Percutaneous ablation is an emerging minimally invasive treatment modality for renal tumors.

Purpose of the Study:

  • To provide a comprehensive overview of percutaneous ablation for renal cancer.
  • To discuss the clinical indications, procedural techniques, and outcomes associated with percutaneous ablation of renal tumors.

Main Methods:

  • Review of current literature on percutaneous ablation techniques for renal cancer.
  • Analysis of clinical data regarding indications, methods, and results of percutaneous ablation.

Main Results:

  • Percutaneous ablation is indicated for specific renal tumors, often based on size and location.
  • The technique involves minimally invasive delivery of ablative energy (e.g., heat, cold) to destroy tumor cells.
  • Outcomes include tumor destruction and preservation of renal function, with varying recurrence rates.

Conclusions:

  • Percutaneous ablation is a viable and effective treatment option for select patients with early renal cancer.
  • The technique offers a minimally invasive alternative to traditional surgical interventions.
  • Further research and standardized reporting are needed to optimize outcomes and indications.